%I WILEY
%J ARTHRITIS & RHEUMATOLOGY
%L discovery10090942
%V 71
%K Animal models, PPAR and Pulmonary hypertension, Systemic sclerosis
%C Atlanta, GA, USA
%D 2019
%O This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
%T The PPAR Agonist Lanifibranor Protects Against Right Ventricular Hypertrophy in a Mouse Model of Systemic Sclerosis Associated Pulmonary Hypertension
%A E Derrett-Smith
%A K Clark
%A S Xu
%A D Abraham
%A O Lacombe
%A P Broqua
%A J-L Junien
%A I Konstantinova
%A C Denton